US Patent Issued to FANTASIA BIOPHARMA (ZHEJIANG) on April 14 for "Coronavirus pseudovirus packaging system, packaging method therefor, and application of coronavirus pseudovirus in evaluating disinfection efficacy" (Chinese Inventors)

ALEXANDRIA, Va., April 15 -- United States Patent no. 12,600,988, issued on April 14, was assigned to FANTASIA BIOPHARMA (ZHEJIANG) Co. LTD (Jinhua, China).

"Coronavirus pseudovirus packaging system, packaging method therefor, and application of coronavirus pseudovirus in evaluating disinfection efficacy" was invented by Frank Xiaofeng Qin (Jinhua, China), Zhiming Wei (Jinhua, China), Limei Long (Jinhua, China), Renxiang Yang (Jinhua, China) and Fan Li (Jinhua, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A packaging system for a coronavirus pseudovirus, including a vesicular stomatitis virus (VSV) vector in which Fluc and EGFP dual-reporter genes replace a GP gene, and packaging cell that expresses ...